Minai-Azary Jennifer Lynn
SEC insider (Form 3/4/5 filer). CIK 0001844398. Chief Financial Officer at Context Therapeutics Inc. (CNTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 19, 2026. Located in PHILADELPHIA, PA.
Companies Minai-Azary Jennifer Lynn has filed insider reports for
- Context Therapeutics Inc. (CNTX): Officer, Chief Financial Officer
Minai-Azary Jennifer Lynn
CIK: 0001844398
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CNTX
Context Therapeutics Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Feb 19, 2026CNTX
Context Therapeutics Inc.
AwardDirectStock Option (right to buy)
275K shares- - Jun 6, 2025CNTX
Context Therapeutics Inc.
PurchaseDirect40K shares at avg. $0.64$25K - Feb 13, 2025CNTX
Context Therapeutics Inc.
AwardDirectStock Option (right to buy)
371.8K shares-
1-3 of 3 transactions